Health Catalyst (NASDAQ:HCAT) and Dialogue Health Technologies (OTCMKTS:DLHTF) Head-To-Head Review

Dialogue Health Technologies (OTCMKTS:DLHTF) and Health Catalyst (NASDAQ:HCAT) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Earnings and Valuation

This table compares Dialogue Health Technologies and Health Catalyst”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dialogue Health Technologies	N/A	N/A	N/A	N/A	N/A
Health Catalyst	$311.14 million	0.54	-$177.97 million	($3.72)	-0.61

Dialogue Health Technologies has higher earnings, but lower revenue than Health Catalyst.

Analyst Recommendations

This is a breakdown of current recommendations for Dialogue Health Technologies and Health Catalyst, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dialogue Health Technologies	0	0	0	0	0.00
Health Catalyst	1	8	4	0	2.23

Health Catalyst has a consensus target price of $2.93, suggesting a potential upside of 28.59%. Given Health Catalyst’s stronger consensus rating and higher probable upside, analysts clearly believe Health Catalyst is more favorable than Dialogue Health Technologies.

Profitability

This table compares Dialogue Health Technologies and Health Catalyst’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Dialogue Health Technologies	N/A	N/A	N/A
Health Catalyst	-87.69%	-3.52%	-1.77%

Insider and Institutional Ownership

85.0% of Health Catalyst shares are owned by institutional investors. 19.4% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Health Catalyst beats Dialogue Health Technologies on 6 of the 9 factors compared between the two stocks.

About Dialogue Health Technologies

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada, the United Kingdom, Germany, and Internationally. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company's platform also enables its members and their dependents to access employee assistance program. Dialogue Technologies Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.

About Health Catalyst

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.